Underrepresentation in clinical trials leads to cancer disparities, says Fox Chase Cancer Center’s Camille Ragin
Cancer survival rates are up, and death rates are down — yet racial minorities still bear a disproportionate burden of cancer, according toCancer Center’s Camille Ragin, who studies racial disparities in cancer, says underrepresentation in clinical trials is among the underlying causes of cancer disparities that’s critical to address.Clinical trials are the backbone of cancer research, helping scientists and doctors better understand what new treatments will be most effective in treating cancer.
The Inquirer spoke to Ragin, an epidemiologist and associate director of diversity, equity, and inclusion at Fox Chase, about how the Philadelphia comprehensive cancer center and others can reduce disparities by improving diversity in clinical trials.One person’s cancer is not the same as another’s. It’s the same way when you view populations — there are so many subgroups, different ethnic groups.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: Medscape - 🏆 386. / 55 Read more »